299 related articles for article (PubMed ID: 15270095)
1. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels.
Marinho CR; Bastos KR; Sardinha LR; Grisotto MG; Lima MR; Alvarez JM
J Parasitol; 2004 Jun; 90(3):516-23. PubMed ID: 15270095
[TBL] [Abstract][Full Text] [Related]
2. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease.
Marinho CR; D'Império Lima MR; Grisotto MG; Alvarez JM
Infect Immun; 1999 Jan; 67(1):308-18. PubMed ID: 9864231
[TBL] [Abstract][Full Text] [Related]
3. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
Nickell SP; Sharma D
Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
Abrahamsohn IA; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
[TBL] [Abstract][Full Text] [Related]
7. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
[TBL] [Abstract][Full Text] [Related]
8. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
Solana ME; Alba Soto CD; Fernández MC; Poncini CV; Postan M; González Cappa SM
Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
[TBL] [Abstract][Full Text] [Related]
9. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
12. Parasite antigen-induced IFN-gamma and IL-4 production by cells from pathopermissive and pathoresistant strains of mice infected with Trypanosoma cruzi.
Humphrey JS; McCormick TS; Rowland EC
J Parasitol; 1997 Jun; 83(3):533-6. PubMed ID: 9194843
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
Miller MJ; Wrightsman RA; Manning JE
Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
15. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
Nabors GS; Tarleton RL
J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs.
Carneiro CM; Martins-Filho OA; Reis AB; Veloso VM; Araújo FM; Bahia MT; de Lana M; Machado-Coelho GL; Gazzinelli G; Correa-Oliveira R; Tafuri WL
Acta Trop; 2007 Feb; 101(2):120-9. PubMed ID: 17296162
[TBL] [Abstract][Full Text] [Related]
17. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
Miller MJ; Wrightsman RA; Stryker GA; Manning JE
J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
[TBL] [Abstract][Full Text] [Related]
18. Splenectomy increases mortality in murine Trypanosoma cruzi infection.
Maioli TU; Assis FA; Vieira PM; Borelli P; Santiago H; Alves R; Romanha AJ; Carneiro CM; Faria AM
Scand J Immunol; 2011 Jan; 73(1):36-45. PubMed ID: 21129001
[TBL] [Abstract][Full Text] [Related]
19. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
[TBL] [Abstract][Full Text] [Related]
20. Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.
Rosas-Jorquera CE; Sardinha LR; Pretel FD; Bombeiro AL; D'Império Lima MR; Alvarez JM
Clin Vaccine Immunol; 2013 Feb; 20(2):248-54. PubMed ID: 23254299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
